Arthur Koch is a notable inventor based in Bloomington, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifolate compounds. With a total of 3 patents to his name, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Koch's latest patents focus on the combination of benzoquinazoline antifolates and protecting agents. These patents disclose the use of a protecting agent, such as a folate derivative like folic acid or leucovorin, in conjunction with a non-competitive folic acid analogue, specifically benzoquinazoline derivatives. The aim is to reduce the side effects associated with the administration of these non-competitive folic acid analogues. Additionally, pharmaceutical formulations comprising such combinations are also detailed in his patents.

Career Highlights

Arthur Koch has been associated with SmithKline Beecham Corporation, where he has furthered his research and development efforts. His work in the pharmaceutical industry has been instrumental in advancing the understanding and application of antifolate therapies.

Collaborations

Koch has collaborated with notable colleagues, including Gary Keith Smith and David Stanley Duch. These partnerships have contributed to the innovative research and development of new pharmaceutical solutions.

Conclusion

Arthur Koch's contributions to the field of antifolate research exemplify the importance of innovation in pharmaceuticals. His patents and collaborations highlight his commitment to improving medical treatments and reducing side effects for patients.